Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome

by Mark N. Polizzotto, Thomas S. Uldrick, Duosha Hu, Robert Yarchoan
Published 2017-08-01

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome

by Mark N. Polizzotto, Thomas S. Uldrick, Duosha Hu, Robert Yarchoan
Published 2012-03-01

Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome.

by Nazzarena Labo, Wendell Miley, Vickie Marshall, William Gillette, Dominic Esposito, Matthew Bess, Alexandra Turano, Thomas Uldrick, Mark N Polizzotto, Kathleen M Wyvill, Rachel Bagni, Robert Yarchoan, Denise Whitby
Published 2014-03-01

Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcoma.

by Jana M Kainerstorfer, Mark N Polizzotto, Thomas S Uldrick, Rafa Rahman, Moinuddin Hassan, Laleh Najafizadeh, Yasaman Ardeshirpour, Kathleen M Wyvill, Karen Aleman, Paul D Smith, Robert Yarchoan, Amir H Gandjbakhche
Published 2013-01-01

HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme

by Nila J. Dharan, Tomas Radovich, Samuel Che, Kathy Petoumenos, Prabhjot Juneja, Matthew Law, Robin Huang, Hamish McManus, Mark N. Polizzotto, Rebecca Guy, Peter Cronin, David A. Cooper, Richard T. Gray
Published 2019-01-01